266
Participants
Start Date
November 30, 2011
Primary Completion Date
July 31, 2013
Study Completion Date
August 31, 2013
Epiduo/Tactuo
topical to the face, once daily in the evening
vehicle gel
topical to the face, once daily in the evening
doxycycline 200mg
oral, 2 capsules once daily in the morning with aglass of water and with food
Isotretinoin
oral, 0.5mg/kg/day for a period of four weeks, adjusted to 1 mg/kg/day for the four following months.
Galderma investigational site, Ajax
Galderma investigational site, Barrie
Galderma investigational site, Calgary
Galderma investigational site, Edmonton
Galderma investigational site, Greater Sudbury
Galderma investigational site, Halifax
Galderma investigational site, Hamilton
Galderma investigational site, Markham
Galderma investigational site, Montreal
Galderma investigational site, Newmarket
Galderma investigational site, Oakville
Galderma investigational site, Oshawa
Galderma investigational site, Peterborough
Galderma investigational site, Québec
Galderma investigational site, Richmond Hill
Galderma investigational site, Saint-Hyacinthe
Galderma investigational site, Saskatoon
Galderma investigational site, St. John's
Galderma investigational site, Surrey
Galderma investigational site, Toronto
Galderma investigational site, Vancouver
Galderma investigational site, Waterloo
Galderma investigational site, Windsor
Galderma investigational site, Winnipeg
Galderma investigational site, Woodbridge
Lead Sponsor
Galderma R&D
INDUSTRY